Skip to main content
Egyptian Liver Journal

Table 4 Correlation between serum I-FABP and the studied parameters in group 2 pre- and post-HCV treatment

From: Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

Baseline parameters

Pre-treatment I-FABP level

Post-treatment I-FABP level

Pearson correlation (r)

P -value

Pearson correlation (r)

P -value

AST

(< 35 IU/ml)

0.072

0.618

0.216

0.132

ALT

(< 35 IU/ml)

0.064

0.660

0.340

0.016

FIB4

0.113

0.436

0.283

0.047

APRI score

0.063

0.662

0.245

0.087

FibroScan

(kpa)

 − 0.090-

0.535

0.035

0.808

CAP

(dB/m)

 − 0.067-

0.646

 − 0.063

0.666

HCV RNA PCR

 − 0.040-

0.784

0.085

0.556

CD4 count

 − 0.096-

0.508

0.175

0.223

HIV RNA PCR

 − 0.170-

0.243

 − 0.254

0.078

  1. Abbreviations: APRI AST to platelet ratio index, CAP Controlled attenuation parameter, dB/m decibel per minute, FIB4 Fibrosis-4, kPa kilopascal, n number, ng nanogram
Back to article page